Drugs / Kallunk oxide
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00276991 | Nov 2007 → Oct 2009 | HIV infectious disease | Traditional Alternative Medicine Research, India | Terminated | No outcome recorded Stop: Enrollment |
| Phase 31 trial | ||||||
| Phase 3 | NCT01349062 | Feb 2012 → Feb 2017 | HIV infectious disease | Traditional Alternative Medicine Research, India | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Kallunk oxide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01349062 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “a combination of a traditional alternative medicine(Complementary and Alternative Medicine CAM) as "Kallunk oxide"” NCT00276991 ↗ |